MedTrace Logo

Feasibility of Improving Risk Stratification in Brugada Syndrome

NCT03992677 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2022-08-17

No results posted yet for this study

Summary

Feasibility of Improving Risk Stratification in Brugada Syndrome (BrS), retrospective cohort study To study the reproducibility and specificity of V-CoS for activation heterogeneities predisposing to VT/VF in a larger series of BrS patients and determining the incidence of low V-CoS score in a larger cohort of control patients.

Population of 10 patients undergoing ablation for non-VT arrhythmia, 10 patients with atrial fibrillation, 10 relatives of BrS sufferers, who have confirmation of no pathology,10 patients with previous out-of-hospital cardiac arrest due to ischaemia, but with full revascularisation and recovery of left ventricular function, 10 elite athletes, 50 BrS sufferers with previous sudden cardiac death or appropriate Implantable cardioverter-defibrillator (ICD) therapy for VT/VF.

DURATION 3 years

Conditions

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Imperial College London

    lead OTHER

Principal Investigators

  • Ruth Nicholson · Imperial College London

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-01
Primary Completion
2020-12-01
Completion
2022-08-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03992677 on ClinicalTrials.gov